RecruitingNCT07546682
Propel Drug-Eluting Sinus Implant Family IBUKI Cohort
Studying Congenital rubella syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medtronic
- Intervention
- None, observational standard of care study(other)
- Enrollment
- 100 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2027
Study locations (1)
- Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07546682 on ClinicalTrials.govOther trials for Congenital rubella syndrome
Additional recruiting or active studies for the same condition.